Kymriah यूरोपीय संघ - क्रोएशियाई - EMA (European Medicines Agency)

kymriah

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - drugi antineoplastični agensi - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

Visage Absorbable L-lactide-E-caprolactone copolymer (P(LACL)) Threads मोंटेनेग्रो - क्रोएशियाई - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

visage absorbable l-lactide-e-caprolactone copolymer (p(lacl)) threads

"netpharm" druŠtvo sa ograniČenom odgovornoŠĆu za zastupanje, spoljnu i unutraŠnju trgovinu podgorica - neaktivna implantabilna medicinska sredstva

Evusheld यूरोपीय संघ - क्रोएशियाई - EMA (European Medicines Agency)

evusheld

astrazeneca ab - tixagevimab, cilgavimab - covid-19 virus infection - prevention of covid-19.